Correction: Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation - Scorecard - MDSpire
Advertisement
Correction: Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation
Clinical Scorecard: Correction: Prevalence of Clostridium difficile Infection and Gastrointestinal Pathogens in Pediatric Patients with Inflammatory Bowel Disease During Disease Flare-Ups
At a Glance
Category
Detail
Condition
Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease
Key Mechanisms
Infection and gastrointestinal pathogen prevalence during disease flare-ups
Target Population
Pediatric patients with inflammatory bowel disease
Care Setting
Pediatric healthcare settings
Key Highlights
Correction of author affiliations
Focus on Clostridium difficile infection prevalence
Study on gastrointestinal pathogens during disease exacerbation
Implications for pediatric inflammatory bowel disease management
Updated publication details
Guideline-Based Recommendations
Diagnosis
Consider testing for Clostridium difficile in pediatric IBD patients during flare-ups.
Management
Implement infection control measures in pediatric IBD management.
Monitoring & Follow-up
Regular monitoring for gastrointestinal pathogens in pediatric IBD patients.
Risks
Assess risks associated with Clostridium difficile infection in this population.
Patient & Prescribing Data
Pediatric patients with inflammatory bowel disease
Consider appropriate antibiotic therapy for confirmed Clostridium difficile infection.
Clinical Best Practices
Adhere to infection control protocols in pediatric healthcare settings.
